BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16540492)

  • 21. Clinical evaluation of Parkinson's-related dysphonia.
    Sewall GK; Jiang J; Ford CN
    Laryngoscope; 2006 Oct; 116(10):1740-4. PubMed ID: 17003722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating interactional competencies in Parkinson's disease: the potential benefits of a conversation analytic approach.
    Griffiths S; Barnes R; Britten N; Wilkinson R
    Int J Lang Commun Disord; 2011; 46(5):497-509. PubMed ID: 21899668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acoustic assessment of voice and speech disorders in Parkinson's disease through quick vocal test.
    Rusz J; Cmejla R; Růžičková H; Klempíř J; Majerová V; Picmausová J; Roth J; Růžička E
    Mov Disord; 2011 Aug; 26(10):1951-2. PubMed ID: 21484873
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of Parkinson's disease on vocal-prosodic communication from the perspective of listeners.
    Pell MD; Cheang HS; Leonard CL
    Brain Lang; 2006 May; 97(2):123-34. PubMed ID: 16226803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
    Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
    Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caregivers' experiences of caring for a husband with Parkinson's disease and psychotic symptoms.
    Williamson C; Simpson J; Murray CD
    Soc Sci Med; 2008 Aug; 67(4):583-9. PubMed ID: 18524445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speech treatment for Parkinson's disease.
    Trail M; Fox C; Ramig LO; Sapir S; Howard J; Lai EC
    NeuroRehabilitation; 2005; 20(3):205-21. PubMed ID: 16340101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of intensive voice treatment on tone-language speakers with Parkinson's disease.
    Whitehill TL; Wong LL
    Clin Linguist Phon; 2007; 21(11-12):919-25. PubMed ID: 17972188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K; Sussman JE; Stathopoulos ET
    J Commun Disord; 2014; 52():44-64. PubMed ID: 25459460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social support for physical activity and perceptions of control in early Parkinson's disease.
    Ravenek MJ; Schneider MA
    Disabil Rehabil; 2009; 31(23):1925-36. PubMed ID: 19479519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Speech disorders in Parkinson patients].
    Kerschan K; Pankl W; Auff E
    Wien Klin Wochenschr; 1998 Apr; 110(8):279-86. PubMed ID: 9615959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laryngeal electromyography in adults with Parkinson's disease and voice complaints.
    Zarzur AP; Duprat AC; Shinzato G; Eckley CA
    Laryngoscope; 2007 May; 117(5):831-4. PubMed ID: 17473678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of verbal working memory deficits on metaphor comprehension in patients with Parkinson's disease.
    Monetta L; Pell MD
    Brain Lang; 2007 Apr; 101(1):80-9. PubMed ID: 16875726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential causes and consequences of overlap in talk between speakers with Parkinson's disease and their familiar conversation partners.
    Griffiths S; Barnes R; Britten N; Wilkinson R
    Semin Speech Lang; 2012 Feb; 33(1):27-43. PubMed ID: 22362322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Everyday walking with Parkinson's disease: understanding personal challenges and strategies.
    Jones D; Rochester L; Birleson A; Hetherington V; Nieuwboer A; Willems AM; Van Wegen E; Kwakkel G
    Disabil Rehabil; 2008; 30(16):1213-21. PubMed ID: 18608374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. For better or worse: The effect of levodopa on speech in Parkinson's disease.
    Ho AK; Bradshaw JL; Iansek R
    Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communication changes following non-glottic head and neck cancer management: The perspectives of survivors and carers.
    Nund RL; Rumbach AF; Debattista BC; Goodrow MN; Johnson KA; Tupling LN; Scarinci NA; Cartmill B; Ward EC; Porceddu SV
    Int J Speech Lang Pathol; 2015 Jun; 17(3):263-72. PubMed ID: 25764915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overall intelligibility, language, articulation, voice and resonance characteristics in a child with Shprintzen-Goldberg syndrome.
    Van Lierde KM; Mortier G; Loeys B; Baudonck N; De Ley S; Marks LA; Van Borsel J
    Int J Pediatr Otorhinolaryngol; 2007 May; 71(5):721-8. PubMed ID: 17303258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
    McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
    Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of walking from the perspective of people with Parkinson's disease.
    Hammarlund CS; Andersson K; Andersson M; Nilsson MH; Hagell P
    J Parkinsons Dis; 2014; 4(4):657-63. PubMed ID: 25147140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.